Cargando…
Pediatric population with cystic fibrosis in the centre of Portugal: candidates for new therapies
OBJECTIVES: Cystic fibrosis (CF) is a severe autosomal recessive disease that results from mutations in a gene encoding the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein, a chloride channel. This study aims to characterize the clinical and genetic features of a cohort of pediatr...
Autores principales: | Roda, Juliana, Teixeira, Teresa, AI Silva, Iris, Silva, Teresa Reis, Ferreira, Ricardo, Amaral, Margarida D., Oliveira, Guiomar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432345/ https://www.ncbi.nlm.nih.gov/pubmed/34252371 http://dx.doi.org/10.1016/j.jped.2021.05.010 |
Ejemplares similares
-
New drugs in cystic fibrosis: what has changed in the last decade?
por: Roda, Juliana, et al.
Publicado: (2022) -
Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study
por: Roda, Juliana, et al.
Publicado: (2022) -
Cystic Fibrosis Newborn Screening in Portugal: PAP Value in Populations with Stringent Rules for Genetic Studies
por: Marcão, Ana, et al.
Publicado: (2018) -
Synergy in Cystic Fibrosis Therapies: Targeting SLC26A9
por: Pinto, Madalena C., et al.
Publicado: (2021) -
Pharmacological Modulation of Ion Channels for the Treatment of Cystic Fibrosis
por: Pinto, Madalena C, et al.
Publicado: (2021)